Venture capital firm

Excelerate Health Ventures

A US venture fund investing in B2B pharma technology and tech-enabled pharma services

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Excelerate Health Ventures, abbreviated EHV, is a sector-focused venture fund based in Research Triangle Park, North Carolina, investing in business-to-business pharma technology and tech-enabled pharma services. The firm partners with capital-efficient seed and Series A companies, aiming to help them reach customers, strategic partners, advisors and acquirers across the pharmaceutical, provider and payer sectors. It describes its investment thesis as centred on software and tech-enabled services with large markets and defensible advantages such as proprietary technology, data network effects, or established data flywheels. EHV states that its investors are themselves pharma, provider and payer decision-makers, giving portfolio companies commercial access to potential customers and acquirers alongside capital.

Summary written by TrustList from the business's own published information, Sep 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

Excelerate Health Ventures is ranked on 1 TrustList ranking at #27.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Excelerate Health Ventures has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 1 ranking

#27of 72
Saas investors
It is one of 12 here listing healthtech and one of 18 here listing series a.
Of the top 61 here, 21 also cover artificial intelligence and 19 also cover seed stage; 11 also work in London and 9 also work in San Francisco.
Behind EVP (company), ahead of F2 Capital.

As of 2026-10-31. Organic ranks only; sponsored placements are never ranks. How TrustList ranks